Incurin Tablet
Incurin is an FDA-approved preparation containing Incurin, for veterinary use. Available by prescription.
Estriol, commercially available as Incurin, is a short-acting estrogen hormone utilized in veterinary medicine for its ability to manage specific hormone-responsive clinical signs. It is a prescription medication available for use in female dogs, requiring a valid veterinarian-client-patient relationship before it can be dispensed. It is frequently considered in the context of urinary health for patients presented with incontinence following spaying.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
At a pharmacological level, it replaces the estrogen required to manage the muscle tone of the urethral sphincter. Commonly observed effects include localized digestive changes like vomiting or behavioral shifts including vulvar swelling or signs of attraction from male dogs. Because estrogens can influence bone marrow function, your veterinarian will monitor for observational signs of sensitivity, though this is less frequent with estriol than longer-acting estrogens. Owners should monitor for significant energy shifts and contact their veterinarian promptly with concerns.
Yes. Incurin is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all legal authorizations before any medication is prepared or shipped.
Incurin is a commercial tablet. If your dog requires a customized concentration or a different flavor, Mixlab can discuss specialized compounding options for the active ingredient, estriol, based on a valid prescription.
Veterinarians discuss Incurin because it supports the strength of the bladder neck muscles. By managing the muscle tone, it provides a method for addressing involuntary urine leakage in spayed dogs.
Your veterinarian will monitor for observational signs of improvement, which often occur within the first few days of management. They will adjust the dose to find the most appropriate and suitable level for your dog.
Your veterinarian will provide a specific monitoring schedule to ensure the management approach remains suitable for your dog's long-term health. They will perform regular check-ups to monitor the clinical response.
